Lv7
5100 积分 2021-08-07 加入
A prospective phase 2 study of combination epigenetic therapy against relapsed/refractory peripheral T cell lymphoma
4天前
已完结
Dual epigenetic therapy plus chemotherapy in peripheral T cell lymphoma with T follicular helper phenotype
13天前
已关闭
Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
23天前
已完结
Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial
27天前
已完结
Immunology and targeted therapy in Castleman disease
1个月前
已完结
Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma
2个月前
已完结
First-line immunochemotherapy for extranodal natural killer/T cell lymphoma
2个月前
已完结
First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial
2个月前
已完结
Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma
2个月前
已完结
Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma
2个月前
已完结
皖公网安备34019202002308
